Press Room - Sanofi US News

Menu

Media Room Menu

Month Year

Month Year

Apr 26, 2016

Merial Launches Combination Vaccine to Help Prevent Core Canine Diseases and Provide Comprehensive Leptospirosis Protection
- Photos 1
Apr 1, 2016

Sanofi and Regeneron Announce Positive Dupilumab Topline Results from Two Phase 3 Trials in Inadequately Controlled Moderate-to-Severe Atopic Dermatitis Patients

- Dupilumab is first systemic therapy to show positive Phase 3 results in patients with moderate-to-severe atopic dermatitis, a serious, chronic inflammatory skin disease marked by widespread rash, itching and associated psychosocial comorbidities -
Mar 30, 2016

Sanofi and Regeneron to Present Phase 3 Praluent^® (alirocumab) Injection Clinical Trial Data at ACC.16
Mar 29, 2016

Sanofi Pasteur Collaboration Uses Novel Technology towards Development of a 2nd Generation Influenza Vaccine

Pre-clinical immunogenicity and efficacy data published in Journal of Virology
Mar 16, 2016

Sanofi and Regeneron Strongly Disagree with U.S. Jury Verdict in Ongoing Patent Litigation Regarding Praluent® (alirocumab) Injection and Will Appeal
Mar 11, 2016

Sanofi and Regeneron Announce Topline Results of Phase 3 Monotherapy Study Demonstrating Superiority of Sarilumab vs. Adalimumab in Patients with Active Rheumatoid Arthritis
Mar 4, 2016

Sanofi and Regeneron Announce Humana Provides Exclusive or Preferred Access to Praluent® (alirocumab) Injection on Their Commercial and Medicare Formularies

Praluent is now covered by most health insurance and Medicare plans
Feb 23, 2016

Sanofi US to Return Auvi-Q® (epinephrine injection, USP) Rights to kaléo
- Photos 1
Feb 22, 2016

FDA Accepts Sanofi New Drug Application for Once-Daily Fixed-Ratio Combination of Insulin Glargine and Lixisenatide

- FDA decision anticipated in August 2016 -
Feb 12, 2016

ACT® Advanced Care™ Mouthwash Named 2016 Product of the Year

America's Leading National Consumer Research Survey Ranks ACT Advanced Care #1 in "Oral Care" Category

Show per page

Print
Email page
RSS

You are about to leave www.sanofi.us

If you wish to continue to this external website, click Proceed. It is provided for information only. Sanofi assumes no responsibility for the information presented on this website.